Latest market data

Stock search

ROCHESTER, N.Y., Dec. 21, 2010 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) announced today that it had supplied samples of its Halloysite Nano Tube Technology ("HNT") containing key ingredients for cosmetic products for three of the world's leading cosmetic firms. The samples were prepared at the NNAN facility in Rochester NY during the fourth quarter 2010. NaturalNano's HNT are environmentally friendly components that can be incorporated into a range of cosmetic products utilizing NaturalNano's patented technology.

NaturalNano's Acting CEO & President James Wemett said, "NaturalNano is very pleased to initiate these relationships for additional applications of our HNT. This activity provides an introduction to our HNT technologies to these leading cosmetic companies. It enables us to assess additional cosmetic applications for HNT and build on our established relationship with Fiabila S.A., a world leader in the manufacture of nail polish for a number of well known brands. Wemett continued, "It also provides NNAN with additional revenue for the fourth quarter, 2010. We look forward to continuing to explore additional applications for the use of NNAN with these well known cosmetic companies."

About NaturalNano, Inc.

NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including their proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and licenses 20 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite. www.naturalnano.com

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.